DIASTOP Direct is a probiotic product that contains combination of two lactic acid bacteria:

  • Lactobacillus rhamnosus GG (BIFOLACтм),

  • Bifidobacterium animalis, SSP lactis (BL – 04)

and vitamin D3

™Bifodan Unprotected Trademark.

Pharmaceutical form

Microgranules for direct application, sachets


Lactic acid bacteria are involved in establishing and maintaining the balance and function of the intestinal microflora and contribute to the normal functioning of digestive enzymes, the immune system and intestinal peristalsis. Vitamin D3 additionally helps in establishing and maintaining the natural balance in the intestines, allowing normal function of the gastrointestinal system. Combination of lactic acid bacteria and vitamin D3 enables regulation of the general immune response as well as modulation of the local immune response.


DIASTOP Direct is used for prevention and additional treatment of diarrhea, bloating and other stomach disorders caused by imbalance of the intestinal microflora. Such conditions are:

  • Bacterial and viral gastric and intestinal infections affecting children and adults (eg. rotavirus infections, travelling diarrhea, as well as Helicobacter pylori infection);

  • Treatment with broad-spectrum antibiotics and chemotherapeutic drugs.

Use of lactic acid bacteria in combination with vitamin D3 effectively reduces the frequency and severity of mild to moderate digestive symptoms (mainly diarrhea) that occur due to disruption of normal intestinal microflora and maintains normal intestinal peristalsis.

  • Adults: 1 - 2 sachets per day

  • Children over three years: 1 sachet per day

DIASTOP Direct is intended for oral use only. The content of the sachet is for direct use only, mixing with water or other liquids is not recommended.

DIASTOP Direct does not contain sugar.


Box containing 10 sachets and instruction for use.

Regulatory status

Border product